224 related articles for article (PubMed ID: 37247380)
1. Lifetime prevalence and adherence rate of cervical cancer screening among women living with HIV: a systematic review and meta-analysis.
Gao X; Zhang W; Sun J; Adeloye D; Jin H; Rudan I; Song P; Jin M
J Int AIDS Soc; 2023 May; 26(5):e26090. PubMed ID: 37247380
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Associated factors and global adherence of cervical cancer screening in 2019: a systematic analysis and modelling study.
Zhang W; Gao K; Fowkes FJI; Adeloye D; Rudan I; Song P; Jin M; Chen K
Global Health; 2022 Dec; 18(1):101. PubMed ID: 36494856
[TBL] [Abstract][Full Text] [Related]
4. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Brisson M; Kim JJ; Canfell K; Drolet M; Gingras G; Burger EA; Martin D; Simms KT; Bénard É; Boily MC; Sy S; Regan C; Keane A; Caruana M; Nguyen DTN; Smith MA; Laprise JF; Jit M; Alary M; Bray F; Fidarova E; Elsheikh F; Bloem PJN; Broutet N; Hutubessy R
Lancet; 2020 Feb; 395(10224):575-590. PubMed ID: 32007141
[TBL] [Abstract][Full Text] [Related]
5. Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries.
Lemp JM; De Neve JW; Bussmann H; Chen S; Manne-Goehler J; Theilmann M; Marcus ME; Ebert C; Probst C; Tsabedze-Sibanyoni L; Sturua L; Kibachio JM; Moghaddam SS; Martins JS; Houinato D; Houehanou C; Gurung MS; Gathecha G; Farzadfar F; Dryden-Peterson S; Davies JI; Atun R; Vollmer S; Bärnighausen T; Geldsetzer P
JAMA; 2020 Oct; 324(15):1532-1542. PubMed ID: 33079153
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis.
Desta M; Getaneh T; Yeserah B; Worku Y; Eshete T; Birhanu MY; Kassa GM; Adane F; Yeshitila YG
PLoS One; 2021; 16(11):e0259339. PubMed ID: 34735507
[TBL] [Abstract][Full Text] [Related]
7. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening patterns among HIV-positive women in Estonia: a population-based retrospective cohort study.
Tisler A; Ojavee SE; Veerus P; Soodla P; Uusküla A
BMC Cancer; 2021 Apr; 21(1):350. PubMed ID: 33794821
[TBL] [Abstract][Full Text] [Related]
9. Time to Surgery in Spinal Trauma: A Meta-Analysis of the World's Literature Comparing High-Income Countries to Low-Middle Income Countries.
Chanbour H; Chen JW; Ehtesham SA; Ivey C; Pandey AK; Dewan MC; Zuckerman SL
World Neurosurg; 2022 Nov; 167():e268-e282. PubMed ID: 35948226
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of adjuvant self-administered intravaginal 5-fluorouracil cream following primary treatment of cervical intraepithelial neoplasia grade 2 or 3 among women living with HIV in Kenya: study protocol for a pilot trial.
Mungo C; Bukusi E; Kirkland GE; Ogollah C; Rota G; Omoto J; Rahangdale L
medRxiv; 2023 Dec; ():. PubMed ID: 38168442
[TBL] [Abstract][Full Text] [Related]
11. An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries.
Wells JC; Sharma S; Del Paggio JC; Hopman WM; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Aggarwal A; Sullivan R; Booth CM
JAMA Oncol; 2021 Mar; 7(3):379-385. PubMed ID: 33507236
[TBL] [Abstract][Full Text] [Related]
12. Disparities in cervical cancer screening programs in Cameroon: a scoping review of facilitators and barriers to implementation and uptake of screening.
Woks NIE; Anwi MM; Kefiye TB; Sama DJ; Phuti A
Int J Equity Health; 2023 Aug; 22(1):156. PubMed ID: 37592286
[TBL] [Abstract][Full Text] [Related]
13. Screening for cancer in low- and middle-income countries.
Sankaranarayanan R
Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
[TBL] [Abstract][Full Text] [Related]
14. Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana.
Ramogola-Masire D; Grover S; Mathoma A; Monare B; Gabaitiri L; Bazzett-Matabele L; Hofmeyr G; Morroni C; Luckett R
BMC Womens Health; 2022 Apr; 22(1):100. PubMed ID: 35366863
[TBL] [Abstract][Full Text] [Related]
15. Congenital Cytomegalovirus Infection Burden and Epidemiologic Risk Factors in Countries With Universal Screening: A Systematic Review and Meta-analysis.
Ssentongo P; Hehnly C; Birungi P; Roach MA; Spady J; Fronterre C; Wang M; Murray-Kolb LE; Al-Shaar L; Chinchilli VM; Broach JR; Ericson JE; Schiff SJ
JAMA Netw Open; 2021 Aug; 4(8):e2120736. PubMed ID: 34424308
[TBL] [Abstract][Full Text] [Related]
16. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.
Song P; Rudan D; Zhu Y; Fowkes FJI; Rahimi K; Fowkes FGR; Rudan I
Lancet Glob Health; 2019 Aug; 7(8):e1020-e1030. PubMed ID: 31303293
[TBL] [Abstract][Full Text] [Related]
17. Urban-rural differences in hypertension prevalence in low-income and middle-income countries, 1990-2020: A systematic review and meta-analysis.
Ranzani OT; Kalra A; Di Girolamo C; Curto A; Valerio F; Halonen JI; Basagaña X; Tonne C
PLoS Med; 2022 Aug; 19(8):e1004079. PubMed ID: 36007101
[TBL] [Abstract][Full Text] [Related]
18. The impact of level of education on adherence to breast and cervical cancer screening: Evidence from a systematic review and meta-analysis.
Damiani G; Basso D; Acampora A; Bianchi CB; Silvestrini G; Frisicale EM; Sassi F; Ricciardi W
Prev Med; 2015 Dec; 81():281-9. PubMed ID: 26408405
[TBL] [Abstract][Full Text] [Related]
19. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
Uppal A; Rahman S; Campbell JR; Oxlade O; Menzies D
PLoS Med; 2021 Sep; 18(9):e1003712. PubMed ID: 34520463
[TBL] [Abstract][Full Text] [Related]
20. "My husband says this: If you are alive, you can be someone…": Facilitators and barriers to cervical cancer screening among women living with HIV in India.
Kung TH; Gordon JR; Abdullahi A; Barve A; Chaudhari V; Kosambiya JK; Kumar A; Gamit S; Wells KJ
Cancer Causes Control; 2019 Apr; 30(4):365-374. PubMed ID: 30809741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
